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One sentence condensation of the paper (25 words): In vivo Raman spectroscopy detects 
significant biochemical remodeling in the human cervix over the course of pregnancy and post-
partum period  
 
Short title: In vivo Raman spectroscopy detects significant biochemical remodeling in the human 
cervix over the course of pregnancy 
 
Implications and Contributions (no more than 130 words): Raman spectra were non-invasively 
measured from the cervix of 68 women throughout the course of pregnancy and post-partum 
repair to monitor dynamic biomolecular profiles for improved understanding of cervical 
remodeling. Spectral analysis revealed significant decreases in contributions from extracellular 
matrix (ECM) proteins and significant increases in vascularity throughout the course of 
pregnancy. Parity and body mass index had significant effects on Raman spectra, and may help 
our understanding of adverse outcomes in delivery. This is the first report of Raman spectra 
measured from the cervix in pregnant women and the first study to non-invasively measure 
differences in the cervical biochemical environment based on patient factors. This work has high 
potential for translation and may aid understanding of premature cervical change in populations 
at high risk for preterm birth. 
  
3 
 
Abstract 
BACKGROUND: The cervix must undergo significant biochemical remodeling to allow for 
successful parturition. This process is not fully understood, especially in instances of 
spontaneous preterm birth.  In vivo Raman spectroscopy is an optical technique that can be used 
to investigate the biochemical composition of tissue longitudinally and non-invasively in 
humans, and has been utilized to measure physiology and disease states in a variety of medical 
applications. 
OBJECTIVE: The purpose of this study is to measure in vivo Raman spectra of the cervix 
throughout pregnancy in women, and to identify biochemical markers that change with the 
preparation for delivery and post-partum repair. 
STUDY DESIGN: Sixty-eight healthy pregnant women were recruited. Raman spectra were 
measured from the cervix of each patient monthly in the first and second trimesters, weekly in 
the third trimester, and at the six week post-partum visit. Raman spectra were measured using an 
in vivo Raman system with an optical fiber probe to excite the tissue with 785 nm light. A 
spectral model was developed to highlight spectral regions that undergo the most changes 
throughout pregnancy, which were subsequently used for identifying Raman peaks for further 
analysis. These peaks were analyzed longitudinally to determine if they underwent significant 
changes over the course of pregnancy (p<0.05). Finally, six individual components that comprise 
key biochemical constituents of the human cervix were measured to extract their contributions in 
spectral changes throughout pregnancy using a linear combination method. Patient factors 
including body mass index (BMI) and parity were included as variables in these analyses. 
RESULTS: Raman peaks indicative of extracellular matrix proteins (1248, 1254cm-1) 
significantly decreased (p<0.05), while peaks corresponding to blood (1233 and 1563 cm-1) 
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significantly increased (p<0.0005) in a linear manner throughout pregnancy. In the post-partum 
cervix, significant increases in peaks corresponding to actin (1003, 1339, 1657 cm-1) and 
cholesterol (1447 cm-1) were observed when compared to late gestation, while signatures from 
blood significantly decreased. Post-partum actin signals were significantly higher than early 
pregnancy, whereas extracellular matrix (ECM) proteins and water signals were significantly 
lower than early weeks of gestation. Parity had a significant effect on blood and ECM protein 
signals, with nulliparous patients having significant increases in blood signals throughout 
pregnancy, and higher ECM protein signals in early pregnancy compared to patients with prior 
pregnancies. Body mass index significantly affected actin signal contribution, with low BMI 
patients showing decreasing actin contribution throughout pregnancy and high BMI patients 
demonstrating increasing actin signals.  
CONCLUSION: Raman spectroscopy was successfully used to biochemically monitor cervical 
remodeling in pregnant women during prenatal visits. This foundational study has demonstrated 
sensitivity to known biochemical dynamics that occur during cervical remodeling, and identified 
patient variables that have significant effects on Raman spectra throughout pregnancy. Raman 
spectroscopy has the potential to improve our understanding of cervical maturation, and be used 
as a non-invasive preterm birth risk assessment tool to reduce the incidence, morbidity, and 
mortality caused by preterm birth.   
 
 
Key words (alphabetized): 
Cervical remodeling, in vivo, optical spectroscopy, post-partum, pregnancy, Raman spectroscopy 
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Introduction 
Over half of all spontaneous preterm birth (sPTB) cases do not fall within any specific 
high-risk category, making the prediction and management of sPTB difficult 1. While labor and 
parturition are coordinated processes involving many systems and organs for proper function, a 
full understanding of the cascade leading to labor and parturition has not been achieved, 
particularly in instances of sPTB. An arguably under-investigated but highly important organ for 
pregnancy maintenance and proper labor is the cervix, a dense extracellular matrix (ECM) that is 
infiltrated by cells, blood vessels, and smooth muscle 2,3. The normal process of cervical 
remodeling that facilitates vaginal delivery occurs in four overlapping stages (softening, 
ripening, dilation, and repair) that have unique biochemical features and vary in duration among 
patients 4. Furthermore, these processes are affected by patient factors including parity5-8, prior 
vaginal delivery9, and body mass index (BMI) 10-14.  
Biochemically, the most abundant component of the ECM is fibrillar collagen, accounting 
for  over 70% of the cervix tissue dry weight9. Other important ECM components include elastin, 
hyaluronan, sulfated glycosaminoglycans, proteoglycans, and water. During the softening phase, 
hydration and vascularity increase, remodeling the collagen matrix4. The ripening phase involves 
an accumulation of hydrophilic molecules including glycosaminoglycans such as hyaluronic 
acid, further increasing cervical tissue hydration. Additionally, collagen becomes increasingly 
soluble. While the total amount of collagen remains the same, the collagen concentration 
decreases due to an influx of water and other matrix constituents 15. Next, cervical dilation 
occurs rapidly so the cervix can expand and dilate for delivery. Finally, during cervical repair, 
the collagen matrix of the cervix rebounds through an inflammatory process similar to wound 
healing16,17, with an increase in macrophages and neutrophils that orchestrate ECM rebuilding18. 
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Collagen remodeling occurs in all phases of cervical maturation, and has been identified as the 
most important contributor to the mechanical strength in the cervix 9,19. A firm relationship has 
been established between the extent of collagen cross-linking and tensile strength in both the 
pregnant mouse 20 and human cervix tissues 21-23.  
Researchers are working to develop new tools to quantitatively and non-invasively 
evaluate cervical remodelling in vivo to aid both basic understanding of the remodelling process 
and clinical decision-making. These methods include magnetic resonance, acoustic, mechanical, 
electrical, and optical techniques 24-26. Light-based approaches can enable the study of tissue 
morphology and biochemistry depending on the light-tissue interaction process used. Two 
optical methods have been used in vivo to specifically monitor collagen. Fluorescence from 
collagen can be obtained by exciting tissue at ~340 nm. Previous studies have shown that 
fluorescence decreases over the course of pregnancy in mice and women 27-29. Excitation at ~950 
nm can produce an optical phenomenon termed second harmonic generation in collagen fibers, 
and can be used to create collagen-specific images that show well-defined collagen networks and 
ECM remodeling over the course of pregnancy 30,31. 
Beyond collagen, near-infrared spectroscopy has been used to monitor other factors, 
including hydration, hemoglobin, and optical scatterers by measuring diffuse light scattering 32,33. 
Absorption by hemoglobin and optical scattering were shown to increase hthroughout pregnancy, 
and absorption by water significantly increased during cervical ripening after exposure to the 
prostaglandin misoprostol 32,33. Ectocervix surface area determined by images from an 
endoscopic camera reveal increased surface area in pregnant patients throughout pregnancy, and 
was attributed to increased hydration 34. While fluorescence, second harmonic generation, near-
infrared spectroscopy, and white light imaging have been applied in vivo, these methods provide 
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only a partial measure of the biochemical micro-environment. A single method that can probe 
hydration, proteins, and nuclear content as well as changes in vasculature could evaluate the role 
of each biomarker as well as the interplay between them during cervical remodeling. 
Raman spectroscopy is an inelastic scattering technique that probes the vibrational energy 
levels of molecules. A Raman spectrum contains spectrally narrow peaks which are created by 
light interaction with distinct vibrational modes of molecules and therefore provides specific 
molecular fingerprints that are related to biochemistry and structure. Raman signals 
corresponding to lipids, proteins, saccharides, nucleic acids, and water, offer direct information 
regarding the biochemical makeup of the tissue, and signal intensity is linearly related to 
molecule concentration. Care must be taken during the interpretation of spectra in instances of 
peak overlap, such as the overlap of protein and water at 1657 cm-1. In such cases, all Raman 
features of a given molecule must be analyzed, and spectral unmixing methods may be 
employed. Using Raman spectroscopy for direct understanding of molecular processes is 
difficult in vivo due to the large number of biochemical constituents that contribute to Raman 
spectra. Thus, in vivo information mainly provides relative abundance of biochemical 
constituents and in some cases structure which may be used to inform biology. Due to its high 
sensitivity and specificity, Raman spectroscopy has been increasingly used in biomedical 
applications 35, including detecting dysplasia in the human cervix 36-42. In recent years, sensitivity 
to the hormonal status of cervical tissue has been seen in Raman spectra 43-45, which was the first 
step in using Raman spectroscopy to study cervical remodeling in mouse models of pregnancy 
46,47. Although mouse models allow for observation of pregnancy in a highly controlled manner, 
not all biology is conserved between mice and women, and clinical implementation introduces its 
own set of challenges.  
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The goal of this study is to test the feasibility of measuring Raman spectra of the in vivo 
cervix in pregnant women, and to characterize Raman signatures throughout pregnancy and post-
partum. To this end, sixty-eight pregnant patients were enrolled in the study, and their cervices 
were measured throughout pregnancy and post-partum. Statistical analysis was performed 
longitudinally on the collected spectra, and highly significant changes in the spectra are observed 
as a function of gestation. In addition, patient factors including body mass index and obstetric 
history had significant effects on Raman spectra. To our knowledge, this is the first report using 
Raman spectroscopy to study cervical remodeling in pregnant women, demonstrating feasibility 
of the approach and identifying biochemical features associated with the phases of cervical 
remodeling.  
 
Materials and Methods 
Patient recruitment 
This study was approved by the Vanderbilt University Medical Center’s Institutional 
Review Board (#100544) and followed the guidelines of the Declaration of Helsinki. Pregnant 
patients receiving prenatal care at the Vanderbilt Women’s Health Center were recruited using 
informed, written consent. To be eligible for enrollment, patients had to be at least 18 years old 
and able to provide legally valid prospective informed consent. Relevant patient information 
such as obstetric history, medications, age, BMI, and estimated date of delivery were all included 
in each patient’s research chart. At the end of the study, patient outcome, delivery date and time 
were also recorded. Patient demographics are listed in Table 1. A total of 68 patients were 
enrolled in this study.  
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Experimental setup 
A portable Raman spectroscopy system was used for data collection (Figure 1A). The 
system consists of a 785 nm diode laser (Innovative Photonics Solutions), an imaging 
spectrograph (Kaiser Holospec), a deep-depletion thermoelectrically cooled CCD camera 
(Princeton Instruments), a laptop computer, and a Raman spectroscopy fiber optic probe 
(EmVision LLC). The Raman probe (fiber optic probe approximately 2.1 mm in diameter, plus 
external stainless steel casing totaling 6.3 mm in outer diameter) consists of one optical fiber that 
transmits light from the laser to the tissue, surrounded by seven collection fibers that deliver the 
backscattered light to the spectrograph. The laser power at the sample was set to 80 mW. 
 
Clinical protocol 
After obtaining written, informed consent, the patient underwent a speculum exam 
performed by a certified Women’s Health Nurse Practitioner. The cervix was exposed and 
cleaned with a cotton swab soaked in sterile saline before the Raman probe was gently placed in 
contact with the cervix to obtain a Raman spectrum (Figure 1B). The overhead room lights were 
turned off, and 3-5 measurements were taken from separate locations around the ectocervix, 
taking care to ensure that the probe was placed on the squamous epithelium. Each measurement 
used an integration time of 3 seconds, and the entire process took less than 10 minutes per visit. 
The Raman probe was disinfected after each patient in accordance with standard disinfection 
procedures. For each patient, spectra were acquired monthly in the first and second trimester, 
weekly in the third trimester, and at six week post-partum. 
 
Data processing 
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Each day, the Raman spectroscopy system was wavelength calibrated using a Neon 
Argon lamp. The exact laser excitation wavelength and Raman shift were calculated using 
acetaminophen and naphthalene standards which have well characterized Raman shifts. The 
spectral response of the system was first determined using a NIST calibrated tungsten lamp, and 
then calibrated daily using a piece of green glass that has a similar broadband spectrum. The 
resultant calibration factor was applied to each spectrum based on the spectral throughput 
measured each day. Raman spectra were processed to remove ambient background light, noise 
smoothed using a Savitsky-Golay filter, and fluorescence subtracted using the modified 
polynomial method 48.   
 
Data analysis 
In order to determine how the average Raman spectrum changes over the course of 
pregnancy and post-partum, a restricted cubic spline function for Raman shift (cm-1) with "k 
degrees of freedom" or "k-1 knots", where k was set to 65. Sixty-five knots were chosen in order 
to minimize the number of variables in the model without sacrificing spectral information. 
Additional patient variables, including prior vaginal delivery and BMI were incorporated as 
continuous variables in this spectral model, resulting in a series of Raman spectra representative 
of various stages of pregnancy and post-partum. 
Spectral regions that appeared to change throughout pregnancy based on observations 
from the spectral model were used for calculating changes in Raman peaks and Raman peak 
ratios over pregnancy. Peak ratio calculations provide data normalization and thus allow 
improved comparison across datasets with varying signal to noise ratios. Using this approach, the 
following peaks were identified for further analysis: 1006, 1055, 1125, 1157, 1248, 1254, 1304, 
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1339, 1451, 1563, and 1657 cm-1. To determine whether peak or peak ratio intensities changed as 
the cervix prepared for delivery, generalized estimating equations49,50 (GEEs, a type of linear 
model that clusters data obtained from each patient over time in order to account for the inherent 
correlation between measurements from the same patient) were developed for longitudinal 
monitoring. The change in each peak or peak ratio over time was modeled and plotted with its 
mean and its 95% confidence interval based on the GEE output, and ANOVA was performed on 
the model output to determine statistical significance (* indicates p<0.05 over the course of 
pregnancy). GEE output plots enable the analysis of cervical remodeling as a continuous 
variable, such that the not only the spectral peak levels can be observed in each trimester, but 
also the rate of change within, between, and throughout all trimesters.Next, major biochemical 
contributors to the Raman spectra were tracked throughout pregnancy and post-partum using a 
biochemical model termed non-negative least squares (NNLS) analysis. Pure components known 
to be present in the cervix were measured and the tissue spectrum was recreated using a linear 
combination of the pure components. The components used for the model were measured in their 
pure form and include actin, adenosine triphosphate, cholesterol, collagen type I, 
deoxyribonucleic acid, glucose, glycogen, phosphatidylcholine, phosphatidylethanolamine, 
progesterone, and prostaglandin E2 (Sigma, St. Louis, MO), glucose-6-phosphate (Roche 
Diagnostics GmbH, Mannheim, Germany), hyaluronic acid (Abcam, Cambridge, MA), blood 
(excess human blood from use in IRB-approved protocol #151532), and deionized water. All 
measurements were acquired using the same integration time and are displayed in Supplemental 
Figure 1.                                                                                                                                                                      
Non-negative least squares analysis is most accurate when non-correlated spectral 
components are used in the model; therefore the correlation coefficient between each 
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biochemical signal was calculated (Supplemental Figure 2). If any two biochemical components 
had a Spearman correlation coefficient higher than 0.75, one of the two components was chosen 
to be input for the model and the other was not included. The model was computed using 
MATLAB. The pure component spectra were loaded into a matrix with each column containing 
a pure component spectrum. Patient spectra were input to the model and the best fit coefficients 
from each component were calculated. In addition, the residual between the model fit and the 
tissue spectrum was calculated to ensure all regions of the Raman spectra were adequately 
represented.  
To longitudinally monitor how each biochemical molecule changed throughout 
pregnancy, the biochemical coefficients were analyzed using GEEs as explained above. In 
addition, patient variables including obstetric history (parity) and BMI were incorporated into the 
model as continuous variables to determine their effects on Raman spectra throughout 
pregnancy. Studies have shown that BMI and parity have an influence on the ability of Raman 
Spectroscopy to correctly characterize cervical spectra 51, and are factors that contribute to the 
timing of parturition 10,11,14.  
 
Results 
Spectral changes throughout pregnancy 
Raman spectra collected throughout pregnancy changed significantly as the cervix 
prepared for delivery. Representative spectra from one patient measured throughout her 
pregnancy and post-partum are shown in Figure 1C. Multiple regions show considerable 
variation including 1030-1100 cm-1, 1118-1200 cm-1, 1230-1260 cm-1, 1270-1330 cm-1, 1440-
1460 cm-1, 1550-1600 cm-1, and 1630-1670 cm-1. The post-partum spectrum is particularly 
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distinct from the prenatal measurements, and most closely resembles the earliest measurement 
obtained at the patient’s 8 week prenatal visit. However significant increases in the 1118-1200, 
1300-1350, and 1630-1670 cm-1 regions are observed, unique to the post-partum period.  
The spectral model, which was developed to determine the average Raman spectra over 
the course of pregnancy for the entire patient population studied, is shown in Figure 2. Several 
significant changes were observed over pregnancy and post-partum, which are highlighted by the 
gray shaded regions in Figure 2 (* indicates significant change over the course of pregnancy with 
p<0.05). The 1530-1600 cm-1 region attributed to peaks observed in blood (as seen in Figure 4B) 
increases with advancing gestation, whereas bands characteristic of ECM proteins (as observed 
in the collagen spectrum in Figure 4C) (1030-1100 cm-1, 1230-1290 cm-1, 1440-1460 cm-1, and 
1630-1670 cm-1) and carotenoids (1130-1200 cm-1) decrease throughout pregnancy. In addition, 
the left shoulder of the 1657 cm-1 peak appears to increase (Figure 2). Post-partum, bands 
observed in ECM proteins return to early pregnancy levels and there is significantly higher 
intensity in the 1270-1330 cm-1 range. Although Figure 2 depicts a computational representation 
of the data, the majority of the spectral changes that occurred throughout gestation are seen in the 
example patient spectra in Figure 1C, demonstrating the utility and accuracy of the model. 
Several peaks undergo significant changes over the course of pregnancy (* indicates 
p<0.05), including peaks at 1157, 1248, and 1254 cm-1 which significantly decrease throughout 
pregnancy, and the 1563 cm-1 peak which significantly increases as a function of gestation week 
(Supplemental Figure 3). Post-partum measurements are significantly higher (p<0.05) in the 
1304 and 1339 cm-1 peaks compared to early pregnancy (<22 weeks of gestation), and 
significantly lower in the 1006 and 1657 cm-1 peaks.  A similar comparison of post-partum 
spectra to those taken at the end of gestation (>37 weeks) reveals significantly higher intensities 
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post-partum at 1248, 1254, and 1339 cm-1, and significantly lower intensities in the 1006, 1563, 
and 1657 cm-1. Raman peak ratio calculations reveal many features that change significantly 
throughout pregnancy and post-partum (Figure 3), including the 1254/1304 cm-1 ratio (ECM 
protein to actin & glycogen ratio) which decreases as term approaches (p<0.0001), and is 
significantly lower post-partum compared to early pregnancy (Figure 3A). In addition, the 
1563/1248 cm-1 peak ratio (blood to ECM protein ratio) steadily increases over gestation 
(p<0.0001), and post-partum measurements are significantly lower than late pregnancy (Figure 
3B). The 1157/1339 cm-1 peak ratio (carotenoid to ECM protein ratio) significantly decreases 
throughout gestation until term (p<0.005), and post-partum measurements are significantly lower 
than early pregnancy (Figure 3C).  
 
Raman spectra of purified biochemical components 
Six biochemical components were used to construct the least squares model (actin, blood, 
cholesterol, collagen I, glycogen, and water), and their Raman spectra are depicted in Figure 4A-
F. These spectra showcase the specificity of Raman spectroscopy to different types of 
biomolecules. An example of an in vivo spectrum obtained from cervical tissue, overlaid with its 
least squares fit and resulting residual are displayed in Figure 4G. The residual is small and 
fluctuates above and below zero, with an R2 value of 0.922, indicative of a good fit. 
The contributions of two biochemical components change significantly as a function of 
gestation (* indicates p<0.05), as shown in Figure 5. The contribution from blood significantly 
increases in a linear manner (p<0.0005), whereas the contribution from collagen decreases over 
the course of pregnancy (p<0.0001). Comparing post-partum measurements to early pregnancy 
(<22 weeks of gestation) reveal significantly higher (p<0.05) post-partum levels of actin, and a 
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significantly lower contributions from collagen type I and water. Additionally, comparison of 
post-partum to the end of gestation (>37 weeks of gestation) reveals significantly higher actin 
and cholesterol contribution, and significantly lower blood contribution in the post-partum fits. 
 
Effects of patient variables 
While several patient variables were considered, parity and BMI were found to have an 
effect on Raman spectra during pregnancy and post-partum (Figure 6). From NNLS analysis 
blood/vascularity signals have an inverse relationship with parity, with nulliparous patients 
showing significant increases in blood/vascularity signals as the cervix remodels, compared with 
a relatively stable blood contribution in parous patients (Figure 6A, Supplemental Figure 4A) 
(p<0.05). Individual peak analysis reveals that the 1125 cm-1 peak increases steadily in 
nulliparous patients, but does not increase until about 30 weeks of gestation in parous patients 
(Supplemental Figure 4B). Additionally, the 1254 cm-1 peak is significantly higher at the 
beginning of pregnancy and significantly lower near term in nulliparous patients, although 
parous patients do show decreases in this peak throughout pregnancy (Supplemental Figure 4C). 
Post-partum, parous patients had significantly higher contributions from cholesterol 
(Supplemental Figure 4D), while nulliparous patients had significantly higher intensities at 1006 
(Supplemental Figure 4E) and 1055 cm-1 (possibly caused by ECM proteins or actin) 
(Supplemental Figure 4F) than parous patients.  
Evaluation of the effects of BMI shows that low BMI patients (demonstrated by spectral 
model with BMI=25) have decreasing actin contributions as the cervix prepares for delivery 
(p<0.05) which levels outs as BMI increases (Supplemental Figure 5A). In addition, low BMI 
patients start with higher signal from 1248 cm-1, a peak characteristic of ECM proteins, but 
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decreases to a greater extent than high BMI patients at term (Supplemental Figure 5B). Post-
partum spectra from low BMI patients have higher actin contribution and higher 1003 cm-1 peak 
intensity compared to high BMI patients (demonstrated by model with BMI=40 in Figure 6 and 
in Supplemental Figure 5A&C). In addition, high BMI patients have higher contribution from 
collagen than low BMI patients in the post-partum period (Supplemental Figure 4D).  
 
Comment 
Monitoring the cervix during pregnancy has many purposes; these include improved 
understanding of normal and abnormal physiology of cervical remodeling, estimating delivery 
time, and determining patient readiness for labor. This last clinical task is currently conducted 
using the Bishop Score and in some cases ultrasound; however these methods provide limited 
information, mainly pertaining to cervical structure. In this study, Raman spectroscopy was 
employed to non-invasively measure the biochemistry of the cervix over the course of pregnancy 
in vivo in women for the first time. This approach successfully measured known biochemical 
changes observed in  multiple stages of pregnancy and post-partum repair, and established 
patient variables that affect the remodeling process, demonstrating the utility of Raman 
spectroscopy for cervical evaluation during pregnancy.   
In vivo Raman measurements of the cervix acquired over the course of pregnancy 
revealed characteristic biochemical changes that occur in preparation for delivery. Decreases in 
peaks indicative of extracellular matrix proteins such as collagen (1055, 1248, and 1657 cm-1) 
and increases in peaks corresponding to blood (1233 and 1563 cm-1) are observed in the example 
patient spectra (Figure 1C), the spectral model determined from 68 patients (Figure 2), and the 
non-negative least squares analysis (Figure 5). An increase in blood signatures is attributed to the 
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increase in vascularization that occurs as the cervix prepares for delivery 4 (Figure 5), a 
phenomenon which has also been observed in pregnant women using near infrared 
spectroscopy33. Decreases in ECM peaks are explained by the process of ECM remodeling where 
collagen becomes increasingly soluble due to reduced cross-links and dispersed at a lower 
concentration 4,15. Trivalent collagen cross-links have been observed at 1660 cm-1, and reductions 
in these cross-links (which have been previously reported in women27 and mice27,52) likely 
contribute to the observed decrease in this peak during pregnancy53. Furthermore, the 1657 cm-1 
peak (also known as the amide I region) broadened in preparation for delivery, a phenomenon 
that is known to be caused by structural disorder such as collagen fiber dispersion 54. This 
broadening may also be attributed to increased blood signals which have a peak at 1619 cm-1. In 
pregnant women, collagen solubility has been measured in vivo using laser-induced fluorescence 
where fluorescent intensity corresponding to collagen cross-links was shown to decrease 
throughout pregnancy28. Fiber dispersion has been measured during pregnancy ex vivo in mice 
and women using second harmonic generation55 and optical coherence tomography56. An 
increase in collagen fiber dispersion was seen using both techniques. In the post-partum cervix, 
Raman spectral signatures were significantly different from measurements obtained during 
pregnancy, with increases in spectral features corresponding to actin and cholesterol, and 
decreases in features corresponding to blood, collagen type I,  and water as observed in Figure 5. 
There are few studies focused on understanding post-partum repair, however these studies 
suggest that the repair process is governed by immune cells which infiltrate the cervix and create 
a proinflammatory environment that resembles wound healing 18,57,58. Microarray studies have 
found that in addition to inflammatory genes, matrix synthesis and collagen strengthening genes 
are upregulated in the post-partum cervix 16,17. Based on this evidence, it is possible that the 
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spectral increases of actin and cholesterol are caused by an influx of immune cells and 
fibroblasts. Although post-partum contributions from glycogen did not reach statistical 
significance due to variability in measurement time point (2-12 weeks post-partum), a possible 
explanation for the observed heightened glycogen levels is intensive anabolic activity driving the 
repair process. Furthermore, the peak at 1160 cm-1 is found in many carotenoid antioxidants 59-61 
which could be elevated post-partum to combat high levels of reactive oxygen species related to 
macrophages and neutrophil infiltration.  
Two patient variables, parity and body mass index, affected spectral changes that were 
observed throughout pregnancy and post-partum (Figure 6). Nulliparous patients started 
pregnancy with higher spectral contributions from collagen (based on the NNLS model) 
compared to parous (Figure 6A). In fact, this observation is supported by an ex vivo study in 
which collagen concentration (determined via hydroxyproline assay) was measured from cervical 
biopsies taken from parous and nulliparous women, and revealed decreasing collagen levels as 
parity increased 8. These findings were corroborated with ex vivo biomechanical tests of non-
pregnant tissues from patients with and without prior vaginal deliveries which revealed stiffer, 
less compliant tissue in patients without prior vaginal deliveries 9, and confirmed decreased 
collagen extractability, as well as increased sulfated glycosaminoglycans and hydration in 
patients with a history of prior vaginal delivery. It is likely that a permanent vascular network is 
established during the first pregnancy similar to permanent changes in mechanical properties9, 
which would explain why patients with prior pregnancies had significantly higher baseline 
blood/vascularity levels compared to nulliparous patients. Taken together, these results are 
unsurprising, as multiparous patients generally have faster labors 5-7, indicating that some level 
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of permanent cervical remodeling occurs after completing all four phases of cervical remodeling 
during a prior pregnancy.  
Patients with low BMI have higher spectral signals corresponding to ECM proteins (1248 
cm-1 peak) at the beginning of pregnancy (Figure 6B), but this intensity decreases significantly 
more than high BMI patients by term, indicating that high BMI patients experience a lesserr level 
of ECM remodeling. One possible explanation for this observation is an increase in leptin, an 
adipokine that is elevated in pregnant patients with high BMI, which has been shown to disrupt 
MMP action on collagen in myometrial tissues and synthesize myometrial collagen in late 
pregnancy 14,62,63. It is possible that this phenomenon also occurs in the cervix, reducing the 
extent of cervical remodeling achieved, and contributing to extended labor times and increased 
C-section rates observed in high BMI (>30) patients 10-14. In addition, actin signals decreased 
throughout pregnancy in low BMI patients, possibly caused by cervical cell apoptosis which 
occurs prior to labor 17. However, actin signals did not decrease in high BMI patients, which may 
also be attributed to high leptin levels which have been shown to prevent cell apoptosis in vitro 
14,64.  
Nine of the patients enrolled in the present study underwent preterm birth, ranging from 
35 + 3/7 weeks to 36 +6/7 weeks gestation when they delivered. Analysis was performed to 
determine if any differences were observed in this data set compared to patients who delivered at 
term, but none reached statistical significance. This result is not surprising, as these patients had 
different obstetric histories, body mass indexes, and all delivered relatively close to term. For a 
powered analysis comparing patients with and without PTB, additional studies that specifically 
enroll a large number of high risk patients will be required.  
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Although not yet ready for the launch of a clinical tool, it is important to think about how 
such a tool would be used and incorporated into the current workflow. The long term goals 
include the ability to measure premature cervical change at the patient bedside, as well as 
determine the etiology of the changes measured. The authors envision that Raman measurements 
could be made from the cervix early in pregnancy such as at the first appointment to obtain a 
baseline measurement. The frequency with which measurements would need to be made has not 
yet been established, and will likely require studies that evaluate the cost-benefit analysis of a 
variety of frequencies. Short term, Raman measurements could be introduced as an additional 
test for assessment of premature cervical change and ideally provide clues pointing towards the 
etiology. It is also unclear whether data will need to be normalized to a previous measurement 
taken from the patient, or whether a single measurement could provide enough information to 
determine premature cervical change. Advanced predictive algorithms will need to be developed, 
first indicating abnormal spectral profiles, and then hopefully indicating abnormal changes with 
information regarding etiology. Based on results in this study, variables including parity and 
body mass index will need to be incorporated into the algorithms. In addition to use as a PTB 
risk assessment tool, Raman spectroscopy could be used to aid our biological understanding of 
problems such as cervical insufficiency, ascending infection, and monitoring efficacy of new 
treatment strategies for preterm labor.  
Limitations of this study include the need for validation of the Raman spectral findings. 
Investigation in mouse pregnancy is underway46,47 which has the ability to validate in vivo 
findings from Raman spectra, and future study of patients undergoing hysterectomy will provide 
additional opportunity to compare in vivo Raman spectra to ex vivo biochemical assays. In 
addition, interpretation of Raman spectra can be difficult due to the overlap of many spectral 
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features in biological samples and changes in structure rather than concentration. Although 
Raman spectral intensity and vibrational mode concentration are linear, multiple biochemical 
components may include the same vibrational mode such as C-H stretch found in organic 
molecules. Observing the full spectrum can aid in these cases as distinguishing features likely 
exist between different biomolecules. When using Raman spectroscopy as a biological tool, it is 
important to remember that Raman spectra yield a relative concentration of biochemical species 
comprising tissue at the time of measurement. This information can help in understanding of the 
current microenvironment, but its use for determining molecular function or understanding 
mechanisms of molecular processes is challenging in vivo due to the nature of high overlap from 
thousands of biomolecules. Lastly, in this study, the Raman spectra are not depth-resolved, and 
therefore comment cannot be made regarding whether the biochemical signals originated from 
the cervical epithelium or stroma. For example, it is currently not possible to determine whether 
actin signals originated from epithelial cells or fibroblasts and smooth muscle cells deep in the 
cervical stroma. Raman probes can be developed that allow this capability and may be employed 
in future studies. The main strength of this study lies in the ability to monitor multiple dynamic 
biochemical changes in the cervix as it remodels to deliver the fetus. Although other optical 
modalities are sensitive to certain biochemical components such as collagen or blood, Raman 
spectroscopy provides simultaneous monitoring of ECM proteins, lipids, blood, saccharides, 
antioxidants, and metabolic enzymes without the addition of exogenous labels or removal of 
tissue. This technique has high potential for better understanding the etiologies and progression 
of spontaneous preterm birth, and may also help to unveil the healing process that occurs during 
post-partum repair. Translation of Raman spectroscopy to clinical settings is becoming more 
realistic each year; real-time data processing has already been achieved 65,66, and fully 
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characterized disease and/or physiology profiles allow for automation of data analysis and tissue 
classification at the bedside. Hardware advances are consistently moving forward, which 
promise to reduce complexity of the system 35. These studies also bring us closer to identifying a 
spectral signature that defines cervical changes in normal pregnancy, increasing the potential to 
utilize Raman spectroscopy for predicting the timing of delivery and therefore early risk 
assessment for preterm birth.  
In summary, this study highlights Raman spectroscopy as a tool to track meaningful 
chemical signals in cervical tissue throughout pregnancy and during post-partum repair. This is 
the first study to demonstrate the utility of Raman spectroscopy as a basic research tool in 
obstetrics via its sensitivity to known dynamic biochemical changes that occur during cervical 
remodeling, and marking an important step towards development of a clinical tool. With 
continued advancement, Raman spectroscopy has the potential to improve patient care by arming 
providers with information on the biochemical state of the cervix, close gaps in our 
understanding of cervical maturation, and identify women at risk for preterm birth. 
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Table 1. Patient demographics and outcome. 
Variable  
Total patients (n) 68 
Obstetric History  
       No prior pregnancies (n) 28 
       Prior pregnancies (n) 40 
       Prior vaginal deliveries (n) 30 
Pre-pregnancy BMIa  
       Mean (± SEM) 29.3 (7.6) 
       Underweight/normal (<25) (n) 19 
       Overweight (25-30) (n) 25 
       Obese (30-35) (n) 8 
       Severely obese (35-40) (n) 7 
       Morbidly obese (BMI>40) (n) 8 
Obstetric outcomeb  
       Delivered vaginally at term (n) 32 
       Delivered vaginally preterm (n) 4 
       C-section at term (n) 25 
       C-section preterm (n) 5 
aBMI was not available for one patient 
bOutcome was not available for two patients 
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Figure legends 
Figure 1. In vivo Raman spectroscopy of the cervix during pregnancy. A) Portable Raman 
spectroscopy system; B) Raman probe measurement from the cervix in vivo; C) Raman spectra 
from one patient over the course of her pregnancy and post-partum.     
 
Figure 2. Computational model depicting how Raman spectra change over the course of 
pregnancy and post-partum. Shaded regions indicate spectral bands that exhibited significant 
changes throughout pregnancy: * indicates p<0.05 over the course of pregnancy, # indicates 
p<0.05 when comparing early pregnancy (<20 weeks) and post-partum, and ‡ indicates p<0.05 
when comparing late pregnancy (>37 weeks) to post-partum measurements (p<0.05). Spectral 
regions associated with specific molecular peaks are labeled as such: a- actin, ATP- adenosine 
triphosphate, b-blood, car-carotenoids, chol-cholesterol, col- collagen type I, g-glucose, and w-
water.    
 
Figure 3. In vivo Raman peak ratios displayed in a general linear model over the course of 
pregnancy. * indicates p<0.005 over the course of pregnancy, # indicates p<0.05 when 
comparing early pregnancy (<20 weeks) and post-partum, and ‡ indicates p<0.05 when 
comparing late pregnancy (>37 weeks) to post-partum measurements.    
 
Figure 4. Non-negative least squares biochemical model of in vivo Raman spectra. A-F) Raman 
spectra from pure biochemical components (actin, blood, cholesterol, collagen type I, glycogen, 
and water) and G) a representative cervix tissue spectrum (blue) with its model fit (pink) and 
residual (green). 
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Figure 5. Biochemical contributions over the course of pregnancy. The fitted component 
coefficient for actin (A), blood (B), cholesterol (C), collagen type 1 (D), glycogen (E), and water 
(F), plotted against gestation week (mean and 95% confidence interval). * indicates p<0.005 over 
the course of pregnancy, # indicates p<0.05 when comparing early pregnancy (<20 weeks) and 
post-partum, and ‡ indicates p<0.05 when comparing late pregnancy (>37 weeks) to post-partum 
measurements.  
 
Figure 6. Computational model comparing Raman spectral changes as a function of gestation 
week and post-partum in A) nulliparous (n=29) vs. parous patients (n=37), B) patients with 
normal (model set to BMI=25, n=51) and high (model set to BMI=40, n=15) body mass index. 
Gray bars highlight areas that underwent significant change over pregnancy or post-partum, * and 
# indicate that patient variable had significant effect on spectral region over the course of 
pregnancy and post-partum repair, respectively. 
LaptopLaser Camera
Raman probe
Spectrograph
BA
Os
C Gestation 
(weeks)
PP
-1
Gestation 
(weeks)
-1
PP
*
‡
*
‡#
‡
*
#
‡
#, ‡ a, col, w 
PP
*
*
1
2
5
4
/1
3
0
4
 c
m
-1
ra
ti
o
1
1
5
7
/1
3
3
9
 c
m
-1
ra
ti
o
A C
PP
#
*
1
5
6
3
/1
2
4
8
 c
m
-1
ra
ti
o
B
PP
‡
#
0200
400
600
800
1000
1200
980 1230 1480 1730
In
te
n
s
it
y
 (
C
.u
.)
Raman shift (cm-1)
Cholesterol
0
200
400
600
800
1000
1200
980 1230 1480 1730
In
te
n
s
it
y
 (
C
.u
.)
Raman shift (cm-1)
Water
A
FE
DC
B
G
0
200
400
600
800
1000
1200
980 1230 1480 1730
In
te
n
s
it
y
 (
C
.u
.)
Raman shift (cm-1)
Glycogen
0
200
400
600
800
1000
1200
980 1230 1480 1730
In
te
n
s
it
y
 (
C
.u
.)
Raman shift (cm-1)
Actin
0
200
400
600
800
1000
1200
980 1230 1480 1730
In
te
n
s
it
y
 (
C
.u
.)
Raman shift (cm-1)
Blood
0
200
400
600
800
1000
1200
980 1230 1480 1730
In
te
n
s
it
y
 (
C
.u
.)
Raman shift (cm-1)
Collagen Type I
-50
0
50
100
150
200
250
300
350
400
980 1105 1230 1355 1480 1605 1730
In
te
n
s
it
y
 (
C
.u
.)
Raman Shift (cm-1)
Spectral fit
Cervix tissue
NNLS fit
Residual
*A
FED
CB
actin blood cholesterol
glycogen watercollagen type I
PP PP PP
PP PP PP
‡
‡
#
#*
#, ‡
A Nulliparous Parous
Gestation 
weeks
PP
Raman shift (cm-1) Raman shift (cm-1)
BMI=25 BMI=40
Raman shift (cm-1)
Gestation 
weeks
PP
B
Raman shift (cm-1)
In
te
n
s
it
y
(c
.u
.)
In
te
n
s
it
y
(c
.u
.)
In
te
n
s
it
y
(c
.u
.)
In
te
n
s
it
y
(c
.u
.)
#
#
**
**
**
* *
#
#
##
# #
Supplementary figures
Supplemental Figure 1. Raman spectra of pure chemicals that were evaluated as potential least squares model inputs.
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Supplemental Figure 2. Correlation coefficient matrix comparing similarity between pure chemical Raman spectra. 
Supplemental Figure 3. Raman spectral peak intensities over the progression of pregnancy. * indicated p<0.005 over the course of pregnancy, 
# indicates p<0.05 when comparing early pregnancy (<22 weeks) and post-partum, and ‡ indicates p<0.05 when comparing late pregnancy (>37 
weeks) to post-partum measurements. (Mean and 95% confidence interval)
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Supplemental Figure 4. Non-negative least squares coefficients and Raman spectral peak intensities that have significant differences during 
pregnancy or post-partum based on patient parity. * indicates significant differences (p<0.05) due to parity over the course of pregnancy, # 
indicates significant differences (p<0.05) due to parity when comparing post-partum measurements. (Mean and 95% confidence interval)
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Supplemental Figure 5. Non-negative least squares coefficients and Raman spectral peak intensities that have significant differences based on 
patient body mass index. * indicates significant differences (p<0.05) due to BMI over the course of pregnancy, # indicates significant differences 
(p<0.05) due to BMI when comparing post-partum measurements. (Mean and 95% confidence interval)
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